Evidence map›Paper›PMID 36755346›Full record

ArticleJournal of cheminformatics2023

Efficient virtual high-content screening using a distance-aware transformer model.

Manuel S Sellner, Amr H Mahmoud, Markus A Lill

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Manuel S SellnerDepartment of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Amr H MahmoudDepartment of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Markus A LillDepartment of Pharmaceutical Sciences, University of Basel, Basel, Switzerland. markus.lill@unibas.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular similarity search is an often-used method in drug discovery, especially in virtual screening studies. While simple one- or two-dimensional similarity metrics can be applied to search databases containing billions of molecules in a reasonable amount of time, this is not the case for complex three-dimensional methods. In this work, we trained a transformer model to autoencode tokenized SMILES strings using a custom loss function developed to conserve similarities in latent space. This allows the direct sampling of molecules in the generated latent space based on their Euclidian distance. Reducing the similarity between molecules to their Euclidian distance in latent space allows the model to perform independent of the similarity metric it was trained on. While we test the method here using 2D similarity as proof-of-concept study, the algorithm will enable also high-content screening with time-consuming 3D similarity metrics. We show that the presence of a specific loss function for similarity conservation greatly improved the model's ability to predict highly similar molecules. When applying the model to a database containing 1.5 billion molecules, our model managed to reduce the relevant search space by 5 orders of magnitude. We also show that our model was able to generalize adequately when trained on a relatively small dataset of representative structures. The herein presented method thereby provides new means of substantially reducing the relevant search space in virtual screening approaches, thus highly increasing their throughput. Additionally, the distance awareness of the model causes the efficiency of this method to be independent of the underlying similarity metric.

Indexed as

Deep learningSimilarity searchTransformer modelVirtual screening

Identifiers

PMID36755346
PMCPMC9906956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.